Mesoblast (MESO) News Today $12.10 +0.34 (+2.89%) (As of 12/16/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Mesoblast (NASDAQ:MESO) Hits New 52-Week High - Time to Buy?Mesoblast (NASDAQ:MESO) Hits New 12-Month High - Should You Buy?December 16 at 4:51 PM | marketbeat.comMesoblast (NASDAQ:MESO) Stock Price Up 13.6% - Still a Buy?Mesoblast (NASDAQ:MESO) Shares Up 13.6% - Still a Buy?December 13, 2024 | marketbeat.com3 ASX Growth Companies With Insider Ownership Up To 38%December 9, 2024 | finance.yahoo.comMesoblast’s Revascor Gains FDA Designation BoostDecember 9, 2024 | markets.businessinsider.comFDA Grants Revascor® (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart DiseaseDecember 4, 2024 | globenewswire.comRevascor Improves Survival and Reduces Major Morbidity in High-Risk Ischemic Heart Failure Patients With InflammationDecember 2, 2024 | globenewswire.comTop ASX shares to buy in December 2024November 30, 2024 | msn.comMesoblast Ltd. ADRNovember 27, 2024 | wsj.comMesoblast Announces Director Change and ShareholdingsNovember 18, 2024 | markets.businessinsider.comMesoblast Limited’s AGM Resolutions Gain Strong ApprovalNovember 16, 2024 | markets.businessinsider.comMesoblast (NASDAQ:MESO) Shares Gap Down - Should You Sell?Mesoblast (NASDAQ:MESO) Shares Gap Down - Should You Sell?November 15, 2024 | marketbeat.comMesoblast Limited Advances in Drug Development and CommercializationNovember 15, 2024 | markets.businessinsider.comMesoblast Limited Outlines Future Strategies and Growth ProspectsNovember 15, 2024 | markets.businessinsider.comMesoblast (NASDAQ:MESO) Hits New 52-Week High - What's Next?Mesoblast (NASDAQ:MESO) Reaches New 52-Week High - Here's WhyNovember 13, 2024 | marketbeat.comBuy Rating for Mesoblast Driven by Promising Market Opportunities and Upcoming PDUFA Date for RyoncilNovember 8, 2024 | markets.businessinsider.comMesoblast (NASDAQ:MESO) Stock Price Down 3.7% - Should You Sell?Mesoblast (NASDAQ:MESO) Shares Down 3.7% - What's Next?November 1, 2024 | marketbeat.comHealth Check: PharmX has 99pc share of pharmacy market but reckons it has prescription for growthOctober 31, 2024 | msn.comAppendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024October 30, 2024 | globenewswire.comMesoblast (NASDAQ:MESO) Shares Gap Down - Time to Sell?Mesoblast (NASDAQ:MESO) Shares Gap Down - Here's What HappenedOctober 24, 2024 | marketbeat.comMesoblast Advances Cellular Medicines Amid FDA HopesOctober 19, 2024 | finance.yahoo.comMesoblast (NASDAQ:MESO) Shares Gap Up - Here's What HappenedMesoblast (NASDAQ:MESO) Shares Gap Up - Should You Buy?October 17, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Trading Down 2.4% - Here's WhyMesoblast (NASDAQ:MESO) Trading Down 2.4% - Should You Sell?October 16, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Shares Gap Up - Here's WhyMesoblast (NASDAQ:MESO) Shares Gap Up - What's Next?October 11, 2024 | marketbeat.comWhy Block, Cettire, Mesoblast, and Regis Resources shares are rising todayOctober 10, 2024 | msn.comMarshall Wace LLP Invests $562,000 in Mesoblast Limited (NASDAQ:MESO)Marshall Wace LLP purchased a new stake in shares of Mesoblast Limited (NASDAQ:MESO - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 82,576 shares of the company's stock, valued at apOctober 10, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Stock Price Down 3.5% - Here's What HappenedMesoblast (NASDAQ:MESO) Stock Price Down 3.5% - Here's What HappenedOctober 9, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comWhy Insignia, Light & Wonder, Mesoblast, and Woodside shares are racing higher todayOctober 4, 2024 | msn.comMesoblast (NASDAQ:MESO) Shares Gap Up to $8.76Mesoblast (NASDAQ:MESO) Shares Gap Up to $8.76October 3, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Reaches New 52-Week High at $8.70Mesoblast (NASDAQ:MESO) Reaches New 52-Week High at $8.70October 2, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Trading Up 7.9%Mesoblast (NASDAQ:MESO) Stock Price Up 7.9%September 30, 2024 | marketbeat.comSignal No. 4 up in Batanes, Babuyan Island as Typhoon Julian whips northern LuzonSeptember 30, 2024 | msn.comShort Interest in Mesoblast Limited (NASDAQ:MESO) Rises By 20.5%Mesoblast Limited (NASDAQ:MESO - Get Free Report) was the target of a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 1,010,000 shares, a growth of 20.5% from the August 31st total of 838,200 shares. Based on an average daily volume of 157,200 shares, the short-interest ratio is presently 6.4 days.September 30, 2024 | marketbeat.comMesoblast Option to Issue Up to US$50 Million Convertible Notes for Product LaunchSeptember 29, 2024 | globenewswire.comDr. Roach: Med for Crohn’s disease needs to be changed due to melanomaSeptember 25, 2024 | detroitnews.comMesoblast (NASDAQ:MESO) Stock Rating Upgraded by Maxim GroupMaxim Group raised shares of Mesoblast from a "hold" rating to a "buy" rating and set a $12.00 price target for the company in a report on Tuesday.September 24, 2024 | marketbeat.comMESO Jan 2025 2.000 callSeptember 21, 2024 | ca.finance.yahoo.comMesoblast (NASDAQ:MESO) Trading Up 6.4%Mesoblast (NASDAQ:MESO) Trading 6.4% HigherSeptember 20, 2024 | marketbeat.comMesoblast (MESO): Biotechnology Innovator Nearing Critical Milestones for Life-Changing TherapiesSeptember 19, 2024 | msn.comPet Stem Cells Market Set to Reach $550 Million by 2030 | Exactitude ConsultancySeptember 19, 2024 | finance.yahoo.comMoldovan central bank keeps key rate unchanged at 3.60%September 19, 2024 | ca.finance.yahoo.comMesoblast (NASDAQ:MESO) Shares Gap Up to $6.22Mesoblast (NASDAQ:MESO) Shares Gap Up to $6.22September 16, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Shares Down 3.1% Mesoblast (NASDAQ:MESO) Stock Price Down 3.1%September 13, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Shares Pass Below 50 Day Moving Average of $6.80Mesoblast (NASDAQ:MESO) Share Price Crosses Below 50 Day Moving Average of $6.80September 12, 2024 | marketbeat.comSkye Bioscience (SKYE) Gets a Buy from Piper SandlerSeptember 10, 2024 | markets.businessinsider.comMesoblast (NASDAQ:MESO) Trading Down 4%Mesoblast (NASDAQ:MESO) Stock Price Down 4%September 4, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Cut to "Sell" at StockNews.comStockNews.com downgraded Mesoblast from a "hold" rating to a "sell" rating in a research report on Wednesday.September 4, 2024 | marketbeat.comMesoblast Limited (NASDAQ:MESO) Q4 2024 Earnings Call TranscriptSeptember 4, 2024 | msn.comIs Mesoblast (MESO) The Best Australian Stock To Buy According to Hedge Funds?September 3, 2024 | msn.comMesoblast (NASDAQ:MESO) Shares Gap Up to $6.47Mesoblast (NASDAQ:MESO) Shares Gap Up to $6.47August 30, 2024 | marketbeat.com Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MESO and its competitors with MarketBeat's FREE daily newsletter. Email Address “Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late. MESO Media Mentions By Week MESO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MESO News Sentiment▼1.040.80▲Average Medical News Sentiment MESO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MESO Articles This Week▼33▲MESO Articles Average Week Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MESO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TGTX News Today VKTX News Today BBIO News Today CRNX News Today KRYS News Today ACLX News Today ADMA News Today RARE News Today BHVN News Today APLS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MESO) was last updated on 12/17/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesoblast Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesoblast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
